MedPointe Pharmaceuticals announced that the Food and Drug Administration (FDA) has approved SOMA(R) (carisoprodol) 250 mg as a new recommended dose of SOMA for the relief of discomfort associated with acute, painful musculoskeletal conditions, such as...
Would you like to comment?
Join Diigo for a free account, or sign in if you are already a member.
Page Comments
Would you like to comment?
Join Diigo for a free account, or sign in if you are already a member.